Page last updated: 2024-08-21

dronabinol and gw9662

dronabinol has been researched along with gw9662 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atez, F; Parker, J; Patel, R; Rossetti, RG; Skulas, A; Zurier, RB1
Fishbein-Kaminietsky, M; Gafni, M; Sarne, Y1

Other Studies

2 other study(ies) available for dronabinol and gw9662

ArticleYear
Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid.
    Rheumatology international, 2008, Volume: 28, Issue:7

    Topics: Anilides; Dronabinol; Humans; Interleukin-6; Macrophages; PPAR gamma

2008
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage.
    Journal of neuroscience research, 2014, Volume: 92, Issue:12

    Topics: Anilides; Animals; Arachidonic Acids; Brain; Camphanes; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cognition Disorders; Cyclooxygenase 2; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Encephalitis; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; PPAR gamma; Pyrazoles; Recognition, Psychology

2014